Headline earnings surged 38.8% year-over-year, driven by strong performances from Mediclinic, CIVH, Rainbow, and Heineken Beverages, supporting an 80% interim dividend increase. Portfolio simplification and robust cash generation position the group well amid ongoing macroeconomic and geopolitical volatility.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.